Copyright Reports & Markets. All rights reserved.

Global Antacids Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Antacids Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Antacids Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Antacids Market Size Growth Rate by Type
    • 1.4.2 Proton Pump Inhibitor
    • 1.4.3 H2 Antagonist
    • 1.4.4 Acid Neutralizers
  • 1.5 Market by Application
    • 1.5.1 Global Antacids Market Size Growth Rate by Application
    • 1.5.2 Rx Drug
    • 1.5.3 OTC Drug
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Antacids Market Size, Estimates and Forecasts
    • 2.1.1 Global Antacids Revenue 2015-2026
    • 2.1.2 Global Antacids Sales 2015-2026
  • 2.2 Global Antacids, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Antacids Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Antacids Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Antacids Competitor Landscape by Players

  • 3.1 Antacids Sales by Manufacturers
    • 3.1.1 Antacids Sales by Manufacturers (2015-2020)
    • 3.1.2 Antacids Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Antacids Revenue by Manufacturers
    • 3.2.1 Antacids Revenue by Manufacturers (2015-2020)
    • 3.2.2 Antacids Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Antacids Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Antacids Revenue in 2019
    • 3.2.5 Global Antacids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Antacids Price by Manufacturers
  • 3.4 Antacids Manufacturing Base Distribution, Product Types
    • 3.4.1 Antacids Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Antacids Product Type
    • 3.4.3 Date of International Manufacturers Enter into Antacids Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Antacids Market Size by Type (2015-2020)
    • 4.1.1 Global Antacids Sales by Type (2015-2020)
    • 4.1.2 Global Antacids Revenue by Type (2015-2020)
    • 4.1.3 Antacids Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Antacids Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Antacids Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Antacids Revenue Forecast by Type (2021-2026)
    • 4.2.3 Antacids Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Antacids Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Antacids Market Size by Application (2015-2020)
    • 5.1.1 Global Antacids Sales by Application (2015-2020)
    • 5.1.2 Global Antacids Revenue by Application (2015-2020)
    • 5.1.3 Antacids Price by Application (2015-2020)
  • 5.2 Antacids Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Antacids Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Antacids Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Antacids Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Antacids by Country
    • 6.1.1 North America Antacids Sales by Country
    • 6.1.2 North America Antacids Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Antacids Market Facts & Figures by Type
  • 6.3 North America Antacids Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Antacids by Country
    • 7.1.1 Europe Antacids Sales by Country
    • 7.1.2 Europe Antacids Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Antacids Market Facts & Figures by Type
  • 7.3 Europe Antacids Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Antacids by Region
    • 8.1.1 Asia Pacific Antacids Sales by Region
    • 8.1.2 Asia Pacific Antacids Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Antacids Market Facts & Figures by Type
  • 8.3 Asia Pacific Antacids Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Antacids by Country
    • 9.1.1 Latin America Antacids Sales by Country
    • 9.1.2 Latin America Antacids Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Antacids Market Facts & Figures by Type
  • 9.3 Central & South America Antacids Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Antacids by Country
    • 10.1.1 Middle East and Africa Antacids Sales by Country
    • 10.1.2 Middle East and Africa Antacids Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Antacids Market Facts & Figures by Type
  • 10.3 Middle East and Africa Antacids Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Antacids Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.2 Takeda Pharmaceutical
    • 11.2.1 Takeda Pharmaceutical Corporation Information
    • 11.2.2 Takeda Pharmaceutical Description and Business Overview
    • 11.2.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Takeda Pharmaceutical Antacids Products Offered
    • 11.2.5 Takeda Pharmaceutical Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description and Business Overview
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Antacids Products Offered
    • 11.3.5 Pfizer Related Developments
  • 11.4 Reckitt Benckiser
    • 11.4.1 Reckitt Benckiser Corporation Information
    • 11.4.2 Reckitt Benckiser Description and Business Overview
    • 11.4.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Reckitt Benckiser Antacids Products Offered
    • 11.4.5 Reckitt Benckiser Related Developments
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Description and Business Overview
    • 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bayer Antacids Products Offered
    • 11.5.5 Bayer Related Developments
  • 11.6 Procter＆Gamble
    • 11.6.1 Procter＆Gamble Corporation Information
    • 11.6.2 Procter＆Gamble Description and Business Overview
    • 11.6.3 Procter＆Gamble Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Procter＆Gamble Antacids Products Offered
    • 11.6.5 Procter＆Gamble Related Developments
  • 11.7 GlaxoSmithKline
    • 11.7.1 GlaxoSmithKline Corporation Information
    • 11.7.2 GlaxoSmithKline Description and Business Overview
    • 11.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GlaxoSmithKline Antacids Products Offered
    • 11.7.5 GlaxoSmithKline Related Developments
  • 11.8 Johnson＆Johnson
    • 11.8.1 Johnson＆Johnson Corporation Information
    • 11.8.2 Johnson＆Johnson Description and Business Overview
    • 11.8.3 Johnson＆Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Johnson＆Johnson Antacids Products Offered
    • 11.8.5 Johnson＆Johnson Related Developments
  • 11.9 CONBA
    • 11.9.1 CONBA Corporation Information
    • 11.9.2 CONBA Description and Business Overview
    • 11.9.3 CONBA Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 CONBA Antacids Products Offered
    • 11.9.5 CONBA Related Developments
  • 11.10 Xiuzheng Pharma
    • 11.10.1 Xiuzheng Pharma Corporation Information
    • 11.10.2 Xiuzheng Pharma Description and Business Overview
    • 11.10.3 Xiuzheng Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Xiuzheng Pharma Antacids Products Offered
    • 11.10.5 Xiuzheng Pharma Related Developments
  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Antacids Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.12 Bausch Health
    • 11.12.1 Bausch Health Corporation Information
    • 11.12.2 Bausch Health Description and Business Overview
    • 11.12.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Bausch Health Products Offered
    • 11.12.5 Bausch Health Related Developments
  • 11.13 CR SANJIU
    • 11.13.1 CR SANJIU Corporation Information
    • 11.13.2 CR SANJIU Description and Business Overview
    • 11.13.3 CR SANJIU Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 CR SANJIU Products Offered
    • 11.13.5 CR SANJIU Related Developments
  • 11.14 Reddy'sLaboratories
    • 11.14.1 Reddy'sLaboratories Corporation Information
    • 11.14.2 Reddy'sLaboratories Description and Business Overview
    • 11.14.3 Reddy'sLaboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Reddy'sLaboratories Products Offered
    • 11.14.5 Reddy'sLaboratories Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Antacids Market Estimates and Projections by Region
    • 12.1.1 Global Antacids Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Antacids Revenue Forecast by Regions 2021-2026
  • 12.2 North America Antacids Market Size Forecast (2021-2026)
    • 12.2.1 North America: Antacids Sales Forecast (2021-2026)
    • 12.2.2 North America: Antacids Revenue Forecast (2021-2026)
    • 12.2.3 North America: Antacids Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Antacids Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Antacids Sales Forecast (2021-2026)
    • 12.3.2 Europe: Antacids Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Antacids Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Antacids Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Antacids Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Antacids Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Antacids Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Antacids Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Antacids Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Antacids Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Antacids Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Antacids Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Antacids Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Antacids Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Antacids Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Antacids Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Antacids Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Antacids market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antacids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Antacids market is segmented into
    Proton Pump Inhibitor
    H2 Antagonist
    Acid Neutralizers

    Segment by Application, the Antacids market is segmented into
    Rx Drug
    OTC Drug

    Regional and Country-level Analysis
    The Antacids market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Antacids market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Antacids Market Share Analysis
    Antacids market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antacids business, the date to enter into the Antacids market, Antacids product introduction, recent developments, etc.

    The major vendors covered:
    AstraZeneca
    Takeda Pharmaceutical
    Pfizer
    Reckitt Benckiser
    Bayer
    Procter＆Gamble
    GlaxoSmithKline
    Johnson＆Johnson
    CONBA
    Xiuzheng Pharma
    Sanofi
    Bausch Health
    CR SANJIU
    Reddy'sLaboratories

    Buy now